ArticleRSC advances2020
Superhydrophobic lotus-leaf-like surface made from reduced graphene oxide through soft-lithographic duplication.
Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 54 citations in OpenAlex.
- The Design and Analysis of the Fabrication of Micro- and Nanoscale Surface Structures and Their Performance Applications from a Bionic Perspective.Materials (Basel, Switzerland) · 2024Review
- Investigation and Analysis of Wettability, Anisotropy, and Adhesion in Bionic Upper and Lower Surfaces Inspired by Indocalamus Leaves.Molecules (Basel, Switzerland) · 2024Article
- Recent Advances in the Development of Biomimetic Materials.Gels (Basel, Switzerland) · 2023Review
- Article
- Bionic research onRSC advances · 2022Article
- Superhydrophobic Ni-Reduced Graphene Oxide Hybrid Coatings with Quasi-Periodic Spike Structures.Nanomaterials (Basel, Switzerland) · 2022Article
- Biology and nature: Bionic superhydrophobic surface and principle.Frontiers in bioengineering and biotechnology · 2022Review
- Simple Preparation of Polydimethylsiloxane and Polyurethane Blend Film for Marine Antibiofouling Application.Polymers · 2021Article
- Superhydrophobic graphene-based materials with self-cleaning and anticorrosion performance: An appraisal of neoteric advancement and future perspectives.Colloids and surfaces. A, Physicochemical and engineering aspects · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, reduced graphene oxide (RGO) was used as a material to fabricate superhydrophobic lotus-leaf-like surfaces through soft-lithographic duplication. In the process, a polydimethylsiloxane (PDMS) stamp was prepared by replica molding against the surfaces of fresh lotus leaves that functioned as masters. A dispersion of octadecylamine-modified reduced graphene oxide (ODA-RGO) in tetrahydrofuran (THF) was used as "ink". The lotus-leaf-like surfaces were fabricated by microcontact printing on the solid substrates. The results showed that due to the good processibility of the ODA-RGO dispersion, the printed layers display papillary micro/nano-structures with high fidelity to the surfaces of lotus leaves. The RGO-based lotus-leaf-like surfaces possess superhydrophobic characteristics with a water contact angle larger than 160° and the contact angle hysteresis less than 5°. Due to the excellent chemical stability of the RGO sheets, as-prepared surfaces show remarkable superhydrophobic stability. The lotus-leaf-like surfaces maintain the superhydrophobicity after heating treatment at 150 °C for 24 h or being exposed to corrosive solutions with different pH values for 12 h. The present findings prove that the RGO-based material is an ideal candidate for fabrication of environment-durable lotus-leaf-like surfaces, which can be expected to have applications in different areas.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.